Protein in blood may signal age-related macular degeneration, researchers say
An international team of researchers has identified a new protein that could provide a platform for improved diagnosis and treatment of age-related macular degeneration, or AMD. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 7, 2020 Category: Consumer Health News Source Type: news

With Macular Degeneration, 1 Missed Visit to Eye Doc Can Mean Vision Loss
FRIDAY, Feb. 7, 2020 -- Missing just one eye doctor appointment can result in vision loss in older adults with macular degeneration, a new study warns. Age-related macular degeneration (AMD) is a leading cause of vision loss in the elderly, and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 7, 2020 Category: General Medicine Source Type: news

International team delivers research breakthrough for leading cause of blindness
(Queen Mary University of London) Researchers have identified a new protein linked to age-related macular degeneration (AMD) that could offer new hope for the diagnosis and treatment of the disease, which affects over 1.5 million people in the UK alone. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 7, 2020 Category: International Medicine & Public Health Source Type: news

Visit Adherence, Visual Acuity Linked in Macular Degeneration
THURSDAY, Feb. 6, 2020 -- Adherence to randomized clinical trial visits is associated with visual acuity in individuals with neovascular age-related macular degeneration, according to a study published online Feb. 6 in JAMA Ophthalmology. Meera S.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 6, 2020 Category: Pharmaceuticals Source Type: news

Drug Trials Snapshots: BEOVU
BEOVU is a treatment for neovascular (wet) Age-Related Macular Degeneration (AMD). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 27, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Potential way to halt blinding macular degeneration identified
(University of Virginia Health System) It would be the first treatment for dry age-related macular degeneration and could significantly improve treatment for wet AMD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 22, 2020 Category: International Medicine & Public Health Source Type: news

Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular Degeneration (AMD) and Diabetic Macular Edema
The program, facilitated by Johnson & Johnson Innovation, has the potential to improve the treatment of patients with retinal vascular diseases and transform the lives of those suffering from vision loss. CAMBRIDGE, England, Jan. 13, 2020 -- (Healthcare... Biopharmaceuticals, Ophthalmology Exonate, Janssen Pharmaceuticals, Johnson & Johnson, macular degeneration (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 13, 2020 Category: Pharmaceuticals Source Type: news

Poor Diet Linked to Age-Related Macular Degeneration
Study offers more reasons to limit processed foods, fatty meats and dairy ... You are leaving AARP.org and going to the website of our trusted provider. ... The provider ’s terms, conditions and pol... (Source: AARP.org News)
Source: AARP.org News - January 6, 2020 Category: American Health Source Type: news

Fatty Diets Tied to Vision Loss in Seniors
A study has linked diets high in red meat and fatty foods to age-related macular degeneration in seniors. (Source: WebMD Health)
Source: WebMD Health - December 26, 2019 Category: Consumer Health News Source Type: news

NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace dying cells in retina
NEI-led study to test safety of treatment for a form of age-related macular degeneration that currently lacks treatment. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - December 16, 2019 Category: American Health Source Type: news

Western Diet Linked to Late Age-Related Macular Degeneration
FRIDAY, Dec. 13, 2019 -- Consumption of a Western dietary pattern is associated with an increased likelihood of developing late age-related macular degeneration (AMD), according to a study published online Dec. 6 in the British Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 13, 2019 Category: Pharmaceuticals Source Type: news

Study finds association between poor diet, age-related macular degeneration
(University at Buffalo) Participants who ate a diet high in red and processed meat, fried food, refined grains and high-fat dairy were three times more likely to develop late-stage age-related macular degeneration. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2019 Category: International Medicine & Public Health Source Type: news

Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors
Kodiak Sells Capped Royalty Right on Global Net Sales of KSI-301 for $225 million Royalty Rate of 4.5% on Annual Net Sales Terminates after 4.5 times the Funded Amount Has Been Paid Transaction Enables an Immediate Acceleration of Clinical, Manufactu... Biopharmaceuticals, Ophthalmology, Venture Capital Kodiak Sciences, age-related macular degeneration (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 2, 2019 Category: Pharmaceuticals Source Type: news

Rates of leading cause of blindness will almost DOUBLE in Europe by 2025
Researchers from Bonn University in Germany said ageing populations meant 15 per cent more people across Europe would suffer from age-related macular degeneration in 30 years' time. (Source: the Mail online | Health)
Source: the Mail online | Health - November 12, 2019 Category: Consumer Health News Source Type: news

Yale researchers find cells linked to leading cause of blindness in elderly
Scientists have pinpointed the glial cells and vasculature cells responsible for age-related macular degeneration. (Source: Yale Science and Health News)
Source: Yale Science and Health News - October 24, 2019 Category: Universities & Medical Training Source Type: news

Novartis blockbuster eye med wins FDA approval
Beovu injections treat wet age-related macular degeneration that affects 20 million people worldwide, according to the company (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 8, 2019 Category: Pharmaceuticals Source Type: news

FDA Approves New Injection Brolucizumab (Beovu ) for Wet AMD FDA Approves New Injection Brolucizumab (Beovu ) for Wet AMD
The US Food and Drug Administration approved brolucizumab (Beovu, Novartis) injection for wet age-related macular degeneration (AMD).FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 8, 2019 Category: Drugs & Pharmacology Tags: Ophthalmology News Alert Source Type: news

FDA Approves Beovu (brolucizumab-dbll) for the Treatment of Wet Age-Related Macular Degeneration (AMD)
EAST HANOVER, N.J., Oct. 8, 2019 /PRNewswire/ -- Novartis today announced that the U.S. Food and Drug Administration (FDA) approved Beovu (brolucizumab-dbll) injection, also known as RTH258, for the treatment of wet age-related macular degeneration... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 8, 2019 Category: Drugs & Pharmacology Source Type: news

Reticular Pseudodrusen a Risk for More Rapid AMD Progression Reticular Pseudodrusen a Risk for More Rapid AMD Progression
Patients with reticular pseudodrusen (RPD)-associated age-related macular degeneration (AMD) are at increased risk of progression to geographic atrophy, researchers sayReuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 23, 2019 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Yet Another Health Problem Linked to Air Pollution: Eye Disease
It’s no secret that air pollution isn’t good for your health. In particular, exposure to the byproducts of burning the fuel that powers most of our motor vehicles has been linked to higher risk of lung cancer, respiratory infections, stroke and heart disease, as well as an increased risk of death from these conditions. A new study now adds another worrisome pollution-related risk: eye disease. Dr. Suh-Hang Hank Juo, from the center for myopia and eye disease at China Medical University in Taiwan, and his colleagues documented for the first time in a large population that exposure to two common air pollutants&md...
Source: TIME: Health - August 22, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized health macular degeneration Pollution Source Type: news

High Levels of Exhaust Pollutants May Raise Risk for AMD High Levels of Exhaust Pollutants May Raise Risk for AMD
Exposure to high levels of exhaust may raise the risk of age-related macular degeneration (AMD), a new study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 22, 2019 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Exposure to Air Pollutants May Up Risk for Macular Degeneration
WEDNESDAY, Aug. 21, 2019 -- Chronic exposure to high levels of nitrogen dioxide (NO2) and carbon monoxide (CO) is associated with an increased risk for age-related macular degeneration (AMD) in a population in Taiwan, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 21, 2019 Category: Pharmaceuticals Source Type: news

High levels of exhaust pollutants may raise risk for degenerative eye disease
(Reuters Health) - Exposure to high levels of exhaust may raise the risk of the vision robbing disease called age-related macular degeneration (AMD), a new study suggests. (Source: Reuters: Health)
Source: Reuters: Health - August 21, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Star Trek-style visor helps five blind patients see again
The volunteers, who all had age-related macular degeneration, had taken part in a trial of the French tech firm Pixium Vision's 'bionic' system. (Source: the Mail online | Health)
Source: the Mail online | Health - July 26, 2019 Category: Consumer Health News Source Type: news

New Age-Related Macular Degeneration Common in Untreated Fellow Eyes New Age-Related Macular Degeneration Common in Untreated Fellow Eyes
New age-related macular degeneration (AMD) develops in about a quarter of fellow eyes to those treated for neovascular AMD with intravitreal anti-VEGF agents, according to a post hoc analysis of the VIEW 1 and VIEW 2 studies.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 18, 2019 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Tips for boosting eye health and avoiding macular degeneration
(Natural News) Age-related macular degeneration (AMD) is a disease that can lead to vision loss. It affects over 10 million adults in the U.S. alone, and this number is expected to double by the year 2050. While there is no cure for macular degeneration, certain steps can be taken to boost eye health and decrease the risk of... (Source: NaturalNews.com)
Source: NaturalNews.com - July 15, 2019 Category: Consumer Health News Source Type: news

Reducing the psychological distress of patients diagnosed with a common, retinal disease
(City University London) A new study from City, University of London suggests that effective communication from eye health professionals may help reduce patient fears after they are diagnosed with the 'dry' form of age-related macular degeneration (AMD). Dry AMD is a currently incurable, progressive disease of the macular, the central part of the retina through which we see the world directly in front of us. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 28, 2019 Category: International Medicine & Public Health Source Type: news

Brolucizumab as Good as Aflibercept for Neovascular AMD Brolucizumab as Good as Aflibercept for Neovascular AMD
Brolucizumab is noninferior to aflibercept and requires less-frequent injections for patients with neovascular age-related macular degeneration (nAMD), according to results from two phase-3 trials.Reuters Health Information (Source: Medscape Ophthalmology Headlines)
Source: Medscape Ophthalmology Headlines - June 4, 2019 Category: Opthalmology Tags: Ophthalmology News Source Type: news

FDA OKs Aflibercept (Eylea) for Diabetic Retinopathy FDA OKs Aflibercept (Eylea) for Diabetic Retinopathy
The VEGF inhibitor is already approved for neovascular (wet) age-related macular degeneration, macular edema after central retinal vein occlusion, and diabetic macular edema.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 15, 2019 Category: Drugs & Pharmacology Tags: Ophthalmology News Alert Source Type: news

Personalized 'Eye-in-a-Dish' models reveal genetic underpinnings of macular degeneration
(University of California - San Diego) Using stem cells derived from six people, UC San Diego School of Medicine researchers recapitulated retinal cells in the lab. This 'eye-in-a-dish' model allowed them to identify genetic variants that cause age-related macular degeneration, a common cause of vision loss. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2019 Category: International Medicine & Public Health Source Type: news

Drusen Characteristics Linked With AMD Risk in Fellow Eyes Drusen Characteristics Linked With AMD Risk in Fellow Eyes
In patients with unilateral neovascular age-related macular degeneration (AMD), certain drusen features are associated with conversion to neovascular AMD in the fellow eye, according to a secondary analysis of data from a clinical trial.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - May 5, 2019 Category: Radiology Tags: Ophthalmology News Source Type: news

Donor-Derived iPS Cells Show Promise for Treating Eye Disease
Age-related macular degeneration patients who received injections of retinal cells derived from donors’ induced pluripotent stem cells have maintained their level of eyesight for a year. (Source: The Scientist)
Source: The Scientist - April 30, 2019 Category: Science Tags: News & Opinion Source Type: news

Novartis Announces FDA Filing Acceptance and Priority Review of Brolucizumab (RTH258) for Patients with Wet AMD
Basel, April 15, 2019 - Novartis announced that the US Food and Drug Administration (FDA) accepted the company's Biologics License Application (BLA) for brolucizumab (RTH258) for the treatment of wet age-related macular degeneration (AMD), also... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - April 15, 2019 Category: Drugs & Pharmacology Source Type: news

Calcium Intake Tied to Lower Rate of Late AMD
FRIDAY, April 5, 2019 -- Higher levels of dietary and supplementary calcium intake appear to be associated with a lower incidence of progression to late age-related macular degeneration (AMD), according to a study published online March 21 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 5, 2019 Category: Pharmaceuticals Source Type: news

MPR: Getting medical device development back on track
In this podcast, experts from MPR discuss what medical device companies can do if things go sideways during the product development process. Drawing from their own experiences, engineers from the firm spoke with MassDevice.com editor Sarah Faulkner about how they tackle device development challenges when they are called into action. Sarah Faulkner: Hey, everyone. Thanks for downloading this podcast. I’m really excited to bring you this conversation about what to do when things go sideways during the product development process. Faulkner: I spoke with a group of experts from MPR. They’re a product developm...
Source: Mass Device - April 1, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Featured MPR Source Type: news

Higher Calcium Intake Tied to Slower AMD Progression Higher Calcium Intake Tied to Slower AMD Progression
Higher levels of dietary and supplementary calcium intake are associated with a lower risk of progression to late age-related macular degeneration (AMD), according to a secondary analysis of data from a large trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 30, 2019 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Therapy could improve and prolong sight in those suffering vision loss
(University of California - Berkeley) Ganglion cells in the eye generate noise as the light-sensitive photoreceptors die in diseases such as retinitis pigmentosa. Now, UC Berkeley neurobiologists have found a drug and gene therapy that can tamp down the noise, improving sight in mice with RP. These therapies could potentially extend the period of useful vision in those with degenerative eye diseases, including, perhaps, age-related macular degeneration. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 13, 2019 Category: Biology Source Type: news

Inhibiting post-translational modifications may lower oxidative stress in the aging eye
(Bentham Science Publishers) Advanced age is the largest risk factor for age-related macular degeneration (AMD). Sumoylation is a reversible post-translational modification that conjugates small peptide, small ubiquitin-like modifier (SUMO), to a target protein. Our data indicate sumoylation critically regulates retina and RPE aging and that targeting sumoylation process may provide potential therapeutic strategy for AMD treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 11, 2019 Category: International Medicine & Public Health Source Type: news

Ocular Therapeutix doses first wet-AMD patient in implant trial
Ocular Therapeutix (NSDQ:OCUL) said today that it dosed the first patient in a study of its OTX-TKI tyrosine kinase inhibitor implant. The Phase I trial is slated to assess the bioresorbable device’s safety, durability and tolerability in people with wet age-related macular degeneration. Get the full story at our sister site, Drug Delivery Business News. The post Ocular Therapeutix doses first wet-AMD patient in implant trial appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 20, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Featured Implants Optical/Ophthalmic Pharmaceuticals Wall Street Beat oculartherapeutix Source Type: news

Scientists launch first attempt to halt most common cause of age-related blindness with gene therapy
Surgeons at Oxford University have launched their first attempt at halting age-related macular degeneration, which is the most common cause of blindness and affects 600,000 people in the UK. (Source: the Mail online | Health)
Source: the Mail online | Health - February 18, 2019 Category: Consumer Health News Source Type: news

Protect Your Aging Eyes From Macular Degeneration
FRIDAY, Feb. 15, 2019 -- Age-related macular degeneration (AMD) is an incurable eye disease that affects millions of older Americans, but there are a number of things you can do to reduce your risk, a vision expert says. AMD causes blurred central... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 15, 2019 Category: General Medicine Source Type: news

Single-Cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration
ACD Bio invites you to join them for an educational webinar (Source: The Scientist)
Source: The Scientist - February 13, 2019 Category: Science Tags: Sponsored Webinars Source Type: news

Mayo Clinic Minute: What you need to know about wet macular degeneration
Millions of people deal with age-related macular degeneration as they get older, but many don't understand the difference between types of the condition or what they can do to lessen the effects. Dr. Sophie Bakri, a Mayo Clinic ophthalmologist and retina specialist, explains the differences between wet macular degeneration and dry macular degeneration. Watch: Mayo [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 13, 2019 Category: Databases & Libraries Source Type: news

Mayo Clinic Minute: What you need to know about dry macular degeneration
Millions of people deal with age-related macular degeneration as they get older, but many don't understand the difference between types of the condition or what they can do to lessen the effects. Dr. Sophie Bakri, a Mayo Clinic ophthalmologist and retina specialist, explains the differences between wet macular degeneration and dry macular degeneration. Watch: Mayo [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 12, 2019 Category: Databases & Libraries Source Type: news

NIH researchers home in on genes linked to age-related macular degeneration
Findings point to potential treatment strategies. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - February 11, 2019 Category: American Health Source Type: news

NIH researchers home in on genes linked to age-related macular degeneration
(NIH/National Eye Institute) National Eye Institute scientists led a collaborative study and zeroed in on genes associated with age-related macular degeneration (AMD), a leading cause of vision loss and blindness among people age 65 and older. These findings provide a more expanded and in-depth picture of the genetic contributions to AMD, and they present new pathways for treatment development. The study was published Feb. 11 in Nature Genetics. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 11, 2019 Category: International Medicine & Public Health Source Type: news

Leading eye hospital has been accused of ‘robbing from the blind’
EXCLUSIVE: June Hanson, from a village near Aylesbury, who has age-related macular degeneration, paid £12,000 to the London Eye Hospital for lenses to improve her sight. (Source: the Mail online | Health)
Source: the Mail online | Health - February 4, 2019 Category: Consumer Health News Source Type: news

Ranibizumab and Aflibercept Prompt Comparable Visual Gain in AMD Ranibizumab and Aflibercept Prompt Comparable Visual Gain in AMD
In patients with neovascular age-related macular degeneration (nAMD), aflibercept and ranibizumab achieve similar average visual acuity increases, according Australian researchers.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 31, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

What Are Common Causes of Blindness in Children?
Discussion According to the World Health Organization, about 1.3 billion people have some form of visual impairment. Most people with visual impairments are>50 years old, more are female than male, and more live in resource-limited areas than resource-rich areas. Most visual impairments are avoidable (80%) in all age groups with the leading causes globally and across ages being uncorrected refractive errors and cataracts. The most common causes of blindness are: Refractive errors, uncorrected Cataract Age-related macular degeneration Glaucoma Diabetic retinopathy Corneal opacity Trachoma The exact numbers vary by regi...
Source: PediatricEducation.org - January 28, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

It's possible: Nutritional recommendations that prevent age-related macular degeneration
(Natural News) Saffron is a highly-prized spice with many uses. However, according to several studies, the spice can also be used to reduce your risk of developing age-related macular degeneration. Macular degeneration is the leading cause of blindness in adults aged 50 and older. In the U.S., over 11 million older Americans have some degree of... (Source: NaturalNews.com)
Source: NaturalNews.com - January 26, 2019 Category: Consumer Health News Source Type: news